Application 206854
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DALFAMPRIDINE | DALFAMPRIDINE | TABLET, EXTENDED RELEASE;ORAL | 10MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dalfampridine | DALFAMPRIDINE | Accord Healthcare Inc. | 354a97e8-35c8-418b-91b2-9e8e066cec65 | 2026-11-06 | Warnings, Adverse reactions | Dalfampridine DALFAMPRIDINE |
| Dalfampridine | DALFAMPRIDINE | Golden State Medical Supply, Inc. | 1134ac0f-59c1-a20b-e063-6294a90affcc | 2026-07-28 | Warnings, Adverse reactions | Dalfampridine DALFAMPRIDINE |
| Dalfampridine | DALFAMPRIDINE | Ascend Laboratories, LLC | e10b2d92-2824-4395-8883-6fd52c784aa4 | 2026-07-14 | Warnings, Adverse reactions | Dalfampridine DALFAMPRIDINE |
| AMPYRA | DALFAMPRIDINE | Merz Pharmaceuticals, LLC | 550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783 | 2026-01-16 | Warnings, Adverse reactions | DALFAMPRIDINE |
| DALFAMPRIDINE | DALFAMPRIDINE | Micro Labs Limited | 302c8270-4711-4ca4-bee8-be0738fbe094 | 2025-07-28 | Warnings, Adverse reactions | DALFAMPRIDINE DALFAMPRIDINE |
| Dalfampridine | DALFAMPRIDINE | CivicaScript LLC | c40dcc84-b839-44aa-94f2-886fb1c3d75c | 2025-07-16 | Warnings, Adverse reactions | Dalfampridine DALFAMPRIDINE |
| AMPYRA | DALFAMPRIDINE | Merz Pharmaceuticals, LLC | 974fb2af-7012-4989-b330-e44a31c9c3e5 | 2025-05-05 | Warnings, Adverse reactions | DALFAMPRIDINE |
| DALFAMPRIDINE | DALFAMPRIDINE | Bryant Ranch Prepack | 688eb479-debc-4cfc-a74d-14828c347049 | 2025-02-12 | Warnings, Adverse reactions | DALFAMPRIDINE DALFAMPRIDINE |
| DALFAMPRIDINE | DALFAMPRIDINE | Aurobindo Pharma Limited | 43996322-7d83-4420-9e61-4ed37f710fee | 2024-02-15 | Warnings, Adverse reactions | DALFAMPRIDINE DALFAMPRIDINE |
| Dalfampridine | DALFAMPRIDINE | Sun Pharmaceutical Industries, Inc. | d61e15fa-0334-49a0-ab41-c9a36b726b57 | 2023-10-16 | Warnings, Adverse reactions | Dalfampridine DALFAMPRIDINE |
| Dalfampridine | DALFAMPRIDINE | Actavis Pharma, Inc. | ed826777-b8c4-4d35-aa64-a4c28452baa8 | 2021-12-01 | Warnings, Adverse reactions | Dalfampridine DALFAMPRIDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.